Fortuitous convergences: the beginnings of JUN
暂无分享,去创建一个
[1] P. Vogt,et al. Jun, the oncoprotein , 2001, Oncogene.
[2] Hans van Dam,et al. Distinct roles of Jun : Fos and Jun : ATF dimers in oncogenesis , 2001, Oncogene.
[3] D. Gillespie,et al. Analysis of the Interaction between c-Jun and c-Jun N-terminal Kinase in Vivo * , 1998, The Journal of Biological Chemistry.
[4] D. Gillespie,et al. v-Jun represses c-jun proto-oncogene expression in vivo through a 12-O-tetradecanoylphorbol-13-acetate-responsive element in the proximal gene promoter. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[5] D. Gillespie,et al. The v-Jun oncoprotein replaces p39 c-Jun as the predominant AP-1 constituent in ASV17-transformed fibroblasts: implications for SAPK/JNK-mediated signal transduction. , 1996, Oncogene.
[6] J. Woodgett,et al. Stress-activated protein kinases bind directly to the delta domain of c-Jun in resting cells: implications for repression of c-Jun function. , 1995, Oncogene.
[7] J. N. Mark Glover,et al. Crystal structure of the heterodimeric bZIP transcription factor c-Fos–c-Jun bound to DNA , 1995, Nature.
[8] J. Woodgett,et al. Transcriptional activation by the v-Jun oncoprotein is independent of positive regulatory phosphorylation. , 1994, Oncogene.
[9] A. Kraft,et al. A peptide encoding the c-Jun delta domain inhibits the activity of a c-jun amino-terminal protein kinase. , 1994, The Journal of biological chemistry.
[10] M. Karin,et al. JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain , 1994, Cell.
[11] M. Karin,et al. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. , 1993, Genes & development.
[12] B. Emanuel,et al. Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma , 1993, Nature Genetics.
[13] E. Wagner,et al. c-Jun is essential for normal mouse development and hepatogenesis , 1993, Nature.
[14] J. Woodgett,et al. Co-purification of mitogen-activated protein kinases with phorbol ester-induced c-Jun kinase activity in U937 leukaemic cells. , 1993, Oncogene.
[15] E. Wagner,et al. Bone and haematopoietic defects in mice lacking c-fos , 1992, Nature.
[16] E. Wagner,et al. Embryonic stem (ES) cells lacking functional c-jun: consequences for growth and differentiation, AP-1 activity and tumorigenicity. , 1992, Oncogene.
[17] A. Kraft,et al. Affinity-purified c-Jun amino-terminal protein kinase requires serine/threonine phosphorylation for activity. , 1992, The Journal of biological chemistry.
[18] P. S. Kim,et al. Mechanism of specificity in the Fos-Jun oncoprotein heterodimer , 1992, Cell.
[19] K. Umesono,et al. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PML , 1991, Cell.
[20] B. Vogelstein,et al. p53 mutations in human cancers. , 1991, Science.
[21] Tsonwin Hai,et al. Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[22] C. Chang,et al. Efficient transformation of chicken embryo fibroblasts by c-Jun requires structural modification in coding and noncoding sequences. , 1990, Genes & development.
[23] I. Verma,et al. mXBP/CRE-BP2 and c-Jun form a complex which binds to the cyclic AMP, but not to the 12-O-tetradecanoylphorbol-13-acetate, response element , 1990, Molecular and cellular biology.
[24] N. Jones,et al. Heterodimer formation between CREB and JUN proteins. , 1990, Oncogene.
[25] Y. Nakabeppu,et al. The basic region of Fos mediates specific DNA binding. , 1989, The EMBO journal.
[26] M. Karin,et al. Different requirements for formation of Jun: Jun and Jun: Fos complexes. , 1989, Genes & development.
[27] T. Kouzarides,et al. Leucine zippers of fos, jun and GCN4 dictate dimerization specificity and thereby control DNA binding , 1989, Nature.
[28] P S Kim,et al. Preferential heterodimer formation by isolated leucine zippers from fos and jun. , 1989, Science.
[29] M. Yaniv,et al. Characterization of junD: a new member of the jun proto‐oncogene family. , 1989, The EMBO journal.
[30] R. Tjian,et al. Leucine repeats and an adjacent DNA binding domain mediate the formation of functional cFos-cJun heterodimers. , 1989, Science.
[31] T. Curran,et al. Parallel association of Fos and Jun leucine zippers juxtaposes DNA binding domains. , 1989, Science.
[32] M. Zerial,et al. The product of a novel growth factor activated gene, fos B, interacts with JUN proteins enhancing their DNA binding activity. , 1989, The EMBO journal.
[33] I. Verma,et al. Direct interaction between fos and jun nuclear oncoproteins: role of the 'leucine zipper' domain , 1988, Nature.
[34] Y. Nakabeppu,et al. DNA binding activities of three murine Jun proteins: Stimulation by Fos , 1988, Cell.
[35] Michael E. Greenberg,et al. c-Jun dimerizes with itself and with c-Fos, forming complexes of different DNA binding affinities , 1988, Cell.
[36] B. Franza,et al. Fos and Jun bind cooperatively to the AP-1 site: reconstitution in vitro. , 1988, Genes & development.
[37] I. Verma,et al. fos-associated cellular p39 is related to nuclear transcription factor AP-1 , 1988, Cell.
[38] S. McKnight,et al. The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins. , 1988, Science.
[39] R. Tjian,et al. Fos-associated protein p39 is the product of the jun proto-oncogene. , 1988, Science.
[40] T. Curran,et al. fra-1: a serum-inducible, cellular immediate-early gene that encodes a fos-related antigen , 1988, Molecular and cellular biology.
[41] T. Hunter,et al. Oncogene jun encodes a sequence-specific trans- activator similar to AP-1 , 1988, Nature.
[42] B. Franza,et al. The Fos complex and Fos-related antigens recognize sequence elements that contain AP-1 binding sites. , 1988, Science.
[43] L. Lau,et al. A gene activated by growth factors is related to the oncogene v-jun. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[44] B. Spiegelman,et al. Common DNA binding site for Fos protein complexesand transcription factor AP-1 , 1988, Cell.
[45] R. Tjian,et al. Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1. , 1987, Science.
[46] K. Struhl. The DNA-binding domains of the jun oncoprotein and the yeast GCN4 transcriptional activator protein are functionally homologous , 1987, Cell.
[47] K. Struhl,et al. GCN4, a eukaryotic transcriptional activator protein, binds as a dimer to target DNA. , 1987, The EMBO journal.
[48] M. Karin,et al. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor , 1987, Cell.
[49] R. Tjian,et al. Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements , 1987, Cell.
[50] P. Vogt,et al. Avian sarcoma virus 17 carries the jun oncogene. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[51] R. Doolittle,et al. Homology between the DNA-binding domain of the GCN4 regulatory protein of yeast and the carboxyl-terminal region of a protein coded for by the oncogene jun. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[52] R. Tjian,et al. Activation of transcription by two factors that bind promoter and enhancer sequences of the human metallothionein gene and SV40 , 1987, Nature.
[53] K. Struhl,et al. Functional dissection of a eukaryotic transcriptional activator protein, GCN4 of Yeast , 1986, Cell.
[54] N. Heisterkamp,et al. Evidence of a new chimeric bcr/c-abl mRNA in patients with chronic myelocytic leukemia and the Philadelphia chromosome. , 1985, The New England journal of medicine.
[55] K. Struhl,et al. GCN4 protein, synthesize in vitro, binds HIS3 regulatory sequences: Implications for general control of amino acid biosynthetic genes in yeast , 1985, Cell.
[56] A. Hinnebusch. A hierarchy of trans-acting factors modulates translation of an activator of amino acid biosynthetic genes in Saccharomyces cerevisiae , 1985, Molecular and cellular biology.
[57] G. Thireos,et al. 5' untranslated sequences are required for the translational control of a yeast regulatory gene. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[58] G. Lucchini,et al. Positive regulatory interactions of the HIS4 gene of Saccharomyces cerevisiae , 1984, Molecular and cellular biology.
[59] T. Curran,et al. FBJ murine osteosarcoma virus: identification and molecular cloning of biologically active proviral DNA , 1982, Journal of virology.
[60] R. Weinberg,et al. Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene , 1982, Nature.
[61] C. Der,et al. Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[62] T. Curran,et al. Candidate product of the FBJ murine osteosarcoma virus oncogene: characterization of a 55,000-dalton phosphoprotein , 1982, Journal of virology.
[63] T. Curran,et al. Identification of a 39,000-dalton protein in cells transformed by the FBJ murine osteosarcoma virus. , 1982, Virology.
[64] H. Iba,et al. Cloning and characterisation of the mouse fra-2 gene. , 1994, Oncogene.
[65] P. Sassone-Corsi,et al. fos and jun interaction: The role of the leucine zipper , 1989, International journal of cancer. Supplement = Journal international du cancer. Supplement.
[66] M. Karin,et al. Jun and v-jun contain multiple regions that participate in transcriptional activation in an interdependent manner. , 1989, The New biologist.
[67] A. Hinnebusch,et al. The general control of amino acid biosynthetic genes in the yeast Saccharomyces cerevisiae. , 1986, CRC critical reviews in biochemistry.
[68] M. Barbacid,et al. Transforming genes in human tumors , 1982, Journal of cellular biochemistry.